• FDA approves first smallpox therapy to defend against bioterrorism pharmafile
    July 17, 2018
    The FDA has announced that it has awarded marketing authorisation to SIGA Technologies’ TPOXX (tecovirimat) in the first approval of a drug specifically designed to treatment smallpox. But as the disease was wiped out in 1980, the motivation behind the de
PharmaSources Customer Service